Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Lorenz Trümper | Researchclopedia

Back to researchers

Lorenz Trümper

Universitätsmedizin Göttingen

469

Works

38,951

Citations

80

h-index

231

i10-index

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Viral-associated cancers and disorders

Affiliations

Ontario Institute for Cancer Research1998–1998

Tokyo Medical and Dental University2020–2020

Queen's University Belfast2020–2020

BC Cancer Agency2002–2002

University Hospitals Birmingham NHS Foundation Trust2020–2020

Top Works

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Michael Pfreundschuh,Lorenz Trümper,et al.

20062,075 citations

CAR-T cell therapy research

Cancer Genomics and Diagnostics

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy,Chip Stewart,et al.

20181,922 citations

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Michael Pfreundschuh,Jöerg Schubert,et al.

20081,131 citations

A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

Michael Hummel,Stefan Bentink,et al.

20061,008 citations

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

Andreas Engert,Annette Plütschow,et al.

2010911 citations

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

Michael Pfreundschuh,Evelyn Kuhnt,et al.

2011804 citations

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase,Ulrich Germing,et al.

2007785 citations

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz,Owen A. O’Connor,et al.

2018710 citations

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

Norbert Schmitz,Lorenz Trümper,et al.

2010589 citations